Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma

Blood (2024) 144 (Supplement 1): 367.

https://doi.org/10.1182/blood-2024-203291

Published: 2024

Journal Articles

Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients - the Diadem Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 4574.

https://doi.org/10.1182/blood-2019-127238

Published: 2019

Journal Articles

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Blood (2017) 130 (Supplement 1): 512.

https://doi.org/10.1182/blood.V130.Suppl_1.512.512

Published: 2017

Journal Articles

Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): High Efficacy of High Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC auto-SCT). A Study of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Saad Akhtar, MD, Silvia Montoto, MD, Ariane Boumendil, PhD, Luca Castagna, MD, Herve Finel, Tamas Masszi, MD, Pavel Jindra, MD PhD, Damir Nemet, MD PhD, Herrad Baurmann, MD, Yves Beguin, MD PhD, Felicetto Ferrara, Saveria Capria, MD, Ram Malladi, MD PhD, Jose M Moraleda, MD PhD, Gilles Salles, MD PhD, Adrian Bloor, Julia Meissner, MD, Anna Sureda, MD, Peter Dreger, MD

Blood (2016) 128 (22): 514.

https://doi.org/10.1182/blood.V128.22.514.514

Published: 2016

Journal Articles

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Jan M. Middeke, Min Fang, Jan J. Cornelissen, Brigitte Mohr, Frederick R. Appelbaum, Michael Stadler, Jaime Sanz, Herrad Baurmann, Gesine Bug, Kerstin Schäfer-Eckart, Ute Hegenbart, Tilmann Bochtler, Christoph Röllig, Friedrich Stölzel, Roland B. Walter, Gerhard Ehninger, Martin Bornhäuser, Bob Löwenberg, Johannes Schetelig

Blood (2014) 123 (19): 2960–2967.

https://doi.org/10.1182/blood-2013-12-544957

Published: 2014

Includes: Supplemental data

Journal Articles

Quality Of Life After Allogeneic Stem Cell Transplantation In Patients With Myelofibrosis (CMWP of EBMT)

Nora Machate, Haefaa Alchalby, MD, Susanne Sehner, Tatjana Zabelina, MD, Daniel Wolff, MD, Guido Kobbe, MD, Martin Bornhäuser, MD, Herrad Baurmann, MD, Wolfgang A Bethge, MD, Gerald Wulf, MD, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2013) 122 (21): 2974.

https://doi.org/10.1182/blood.V122.21.2974.2974

Published: 2013

Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis

Blood (2013) 122 (21): 2145.

https://doi.org/10.1182/blood.V122.21.2145.2145

Published: 2013

Journal Articles

Outcome Of Patients With Abnl(17p) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Jan Moritz Middeke, MD, Min Fang, MD, PhD, Jan Cornelissen, MD, PhD, Frederick R. Appelbaum, MD, Brigitte Mohr, Michael Stadler, MD, Miguel Sanz, Herrad Baurmann, MD, Gesine Bug, MD, PhD, Kerstin Schäfer-Eckart, MD, Ute Hegenbart, MD, Tilmann Bochtler, MD, Friedrich Stölzel, MD, Roland B. Walter, MD, PhD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Bob Löwenberg, MD, PhD, Johannes Schetelig, MD, M. Sc

Blood (2013) 122 (21): 303.

https://doi.org/10.1182/blood.V122.21.303.303

Published: 2013

Journal Articles

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Sebastian Michaelis, cand.med., Markus Mezger, PhD, Martin Bornhauser, MD, Rudolf Trenschel, Gernot Stuhler, MD, Matthias Stelljes, MD, Lutz P Mueller, MD, Herrad Baurmann, MD, Birgit Federmann, MD, Lena Oevermann, MD, Lothar Kanz, MD, Rupert Handgretinger, MD, Wolfgang A. Bethge, MD

Blood (2012) 120 (21): 3101.

https://doi.org/10.1182/blood.V120.21.3101.3101

Published: 2012

Journal Articles

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−

Jan M. Middeke, Dietrich Beelen, Michael Stadler, Gudrun Göhring, Brigitte Schlegelberger, Herrad Baurmann, Gesine Bug, Frauke Bellos, Brigitte Mohr, Stefanie Buchholz, Rainer Schwerdtfeger, Hans Martin, Ute Hegenbart, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig

Blood (2012) 120 (12): 2521–2528.

https://doi.org/10.1182/blood-2012-03-417972

Published: 2012

Includes: Supplemental data

Journal Articles

An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission

Blood (2011) 118 (21): 157.

https://doi.org/10.1182/blood.V118.21.157.157

Published: 2011

Journal Articles

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Blood (2011) 118 (21): 1019.

https://doi.org/10.1182/blood.V118.21.1019.1019

Published: 2011

Journal Articles

High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation

Nicola Gökbuget, Nadezda Basara, Herrad Baurmann, Joachim Beck, Monika Brüggemann, Helmut Diedrich, Björn Güldenzoph, Gernot Hartung, Heinz-August Horst, Andreas Hüttmann, Guido Kobbe, Ralph Naumann, Richard Ratei, Albrecht Reichle, Hubert Serve, Matthias Stelljes, Andreas Viardot, Mohammed Wattad, Dieter Hoelzer

Blood (2011) 118 (13): 3504–3511.

https://doi.org/10.1182/blood-2011-01-329441

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation for Patients with AML and FLT-3 Mutations.

Michael Schleuning, MD, Dirk Judith, Mansoor Heshmat, MD, Irina Burlakova, Zuzanna Jedlickova, MD, Elisabeth Salm, MD, Herrad Baurmann, MD, Rainer Schwerdtfeger, MD

Blood (2010) 116 (21): 4573.

https://doi.org/10.1182/blood.V116.21.4573.4573

Published: 2010

Journal Articles

The Impact of Donor Type In Patients with AML and High Risk Cytogenetic Aberrations

Johannes Schetelig, Dietrich Beelen, Michael Stadler, MD, Herrad Baurmann, Gesine Bug, Frauke Bellos, Nicole Birninger, Stefanie Buchholz, Rainer Schwerdtfeger, MD, Hans Martin, Ute Hegenbart, Martin Bornhäuser, Gerhard Ehninger

Blood (2010) 116 (21): 2369.

https://doi.org/10.1182/blood.V116.21.2369.2369

Published: 2010

Journal Articles

Monosomal Karyotype Predicts Survival In Patients with High Risk AML Undergoing Allogeneic Stem Cell Transplantation

Jan Moritz Middeke, Dietrich Beelen, Michael Stadler, MD, Herrad Baurmann, Gesine Bug, Frauke Bellos, Brigitte Mohr, Nicole Birninger, Stefanie Buchholz, Rainer Schwerdtfeger, MD, Hans Martin, Ute Hegenbart, Martin Bornhäuser, Gerhard Ehninger, Johannes Schetelig

Blood (2010) 116 (21): 2748.

https://doi.org/10.1182/blood.V116.21.2748.2748

Published: 2010

Journal Articles

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

Haefaa Alchalby, Anita Badbaran, Tatjana Zabelina, Guido Kobbe, Joachim Hahn, Daniel Wolff, Martin Bornhäuser, Christian Thiede, Herrad Baurmann, Wolfgang Bethge, York Hildebrandt, Ulrike Bacher, Boris Fehse, Axel R. Zander, Nicolaus Kröger

Blood (2010) 116 (18): 3572–3581.

https://doi.org/10.1182/blood-2009-12-260588

Published: 2010

Journal Articles

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Blood (2009) 114 (26): 5264–5270.

https://doi.org/10.1182/blood-2009-07-234880

Published: 2009

Journal Articles

“Clinical and Molecular Heterogeneity of Eosinophilia-Associated Myeloproliferative Neoplasms with a Translocation t(5;12)”.

Darko Gosenca, PhD, Philipp Erben, MD, Claudia Haferlach, MD, Rainer Schwerdtfeger, MD, Herrad Baurmann, Georg Bolz, MD, Juliana Popa, MD, Torsten Haferlach, MD, Wolf-Karsten Hofmann, Andreas Hochhaus, MD, Andreas Reiter, MD

Blood (2009) 114 (22): 4983.

https://doi.org/10.1182/blood.V114.22.4983.4983

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Blood (2009) 114 (22): 1209.

https://doi.org/10.1182/blood.V114.22.1209.1209

Published: 2009

NARROW

Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma

Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients - the Diadem Study from the Chronic Malignancies Working Party of the EBMT

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): High Efficacy of High Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC auto-SCT). A Study of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Quality Of Life After Allogeneic Stem Cell Transplantation In Patients With Myelofibrosis (CMWP of EBMT)

Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis

Outcome Of Patients With Abnl(17p) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−

An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation

Allogeneic Stem Cell Transplantation for Patients with AML and FLT-3 Mutations.

The Impact of Donor Type In Patients with AML and High Risk Cytogenetic Aberrations

Monosomal Karyotype Predicts Survival In Patients with High Risk AML Undergoing Allogeneic Stem Cell Transplantation

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

“Clinical and Molecular Heterogeneity of Eosinophilia-Associated Myeloproliferative Neoplasms with a Translocation t(5;12)”.

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only